<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149818">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02097888</url>
  </required_header>
  <id_info>
    <org_study_id>KSBLB: 252/11</org_study_id>
    <nct_id>NCT02097888</nct_id>
  </id_info>
  <brief_title>Influence of Erythropoietin on Bone Marrow Microenvironment</brief_title>
  <official_title>Influence of Erythropoietin on Bone Marrow Microenvironment: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Baselland Bruderholz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Baselland Bruderholz</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a prospective observational study.  The investigators will compare
      Erythropoietin (Epo) levels, erythropoiesis, and regulators of erythropoiesis, bone imaging
      and bone metabolism in healthy volunteers living at different altitudes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Difference of EPO level between control groups</measure>
    <time_frame>up to 4 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Healthy Men and Non- Pregnant Women</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Samples Without DNA - samples retained, with no potential for DNA extraction from any
      retained samples (e.g., fixed tissue, plasma)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Residents living &lt; 400m over sea level and &gt;1500m over sea level
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy men and non-pregnant women, ages ≥18-40 years and ≥ 60 years living in the
             predefined area

          -  Exclusion Criteria:

          -  Known bone pathology including osteoporosis, known haematological disease, known
             renal disease, heart insufficiency, pulmonal disease

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandrine Meyer-Monard, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Baselland / Bruderholz, Department of Medicine, Studienabteilung, CH-4101 Bruderholz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandrine Meyer-Monard, PD Dr. med.</last_name>
    <phone>041 61 436 22 03</phone>
    <email>sandrine.meyer@ksbl.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helga Schneider</last_name>
    <phone>0041 61 436 31 44</phone>
    <email>helga.schneider@ksbl.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Baselland / Bruderholz</name>
      <address>
        <city>Bruderholz</city>
        <zip>4101</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine Meyer-Monard, PD Dr. med.</last_name>
      <phone>0041 61 436 2203</phone>
      <email>sandrine.meyer@ksbl.ch</email>
    </contact>
    <contact_backup>
      <last_name>Helga Schneider</last_name>
      <phone>0041 61 436 31 44</phone>
      <email>helga.schneider@ksbl.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Sandrine Meyer-Monard, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 24, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kantonsspital Baselland Bruderholz</investigator_affiliation>
    <investigator_full_name>PD Dr. med. Sandrine Meyer-Monard</investigator_full_name>
    <investigator_title>PD Dr. med.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epoetin Alfa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
